Results for tag: "Behcets Disease Drug"

Behcets Disease is a rare, chronic, inflammatory disorder that affects the blood vessels throughout the body. It is characterized by recurrent oral and genital ulcers, skin lesions, and inflammation of the eyes, joints, and other organs. Treatment for Behcets Disease typically involves a combination of medications, including corticosteroids, immunosuppressants, and biologics. Immune Disorders Drugs are a class of medications used to treat a variety of conditions, including Behcets Disease. These drugs work by suppressing the immune system, which helps to reduce inflammation and prevent further damage to the body. Common Immune Disorders Drugs include corticosteroids, immunosuppressants, and biologics. The Behcets Disease Drug market is a subset of the larger Immune Disorders Drugs market. It is composed of a variety of medications used to treat the symptoms of Behcets Disease. These drugs are typically prescribed by a physician and are available in both generic and brand-name formulations. Some companies in the Behcets Disease Drug market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more